Kim Rosko

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

John A Wagner, Rajesh Krishna, Arthur J Bergman, 2007, The Lancet.